Etavopivat
Etavopivat is an orally bioavailable, small-molecule activator of red blood cell pyruvate kinase (PKR) . It demonstrates potent anti-sickling activity in vitro and has shown promise in preclinical models of sickle cell disease for reducing hemolysis and improving red cell health.
Product Specifications
CAS Number
2245053-57-8
Field of Research
Metabolism Research
Purity
99.89% (May vary between batches)
Smiles
S (=O) (=O) (N1CC2=C (C1) CN (C ([C@H] (CO) C3=CC=CC=C3) =O) C2) C=4C=C5C (=NC4) OCCO5
Molecular Formula
C22H23N3O6S
Molecular Weight
457.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6153581-01 0.1 mL
MPZL2 (Myelin Protein Zero-like Protein 2, Epithelial V-like Antigen 1, EVA, EVA1, UNQ606/PRO1192) (HRP)
Sign In for Pricing
View Details